Komori
Kowa (7807) · FactAdvanced

Research and Development Expenditure

First written in FY2018-Q3. 23 of 24 entries say "Advanced", first in FY2018. Latest entry: FY2027-H1.

24entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2018 – FY2027-H12018: 420182019: 420192020: 420202021: 120212022: 320222023: 120232024: 420242025: 120252026: 22026
Same theme, other companies
Recognition and Disclosure of R&D ExpensesA theme 73 companies write about · 0 as a headwind · 21 as a tailwind

8 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 73 companies compared. The sentences above are computed from all 73.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1AdvancedAnnual report

    「The total cost of research and development activities conducted by the group during the interim consolidated accounting period was ¥24 million.」

    Interim research and development expenditure has been updated to ¥24 million.
  2. FY2026AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥60.536 million,」

    Full-year research and development expenses were updated to ¥60.536 million.
  3. FY2026-H1AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the current interim consolidated accounting period were ¥31 million.」

    Cumulative interim research and development expenses were updated to ¥31 million.
  4. FY2025-H1AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the current interim consolidated accounting period were ¥40 million.」

    Research and development expenses for the current interim consolidated accounting period were updated to ¥40 million. There were no material changes in the status of research and development activities.
  5. FY2025-Q1AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative first quarter of the current consolidated fiscal year were ¥23 million.」

    Cumulative research and development expenses for the first quarter were updated to ¥23 million.
  6. FY2024AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥91.572 million,」

    Full-year research and development expenses were updated to ¥91.572 million, up from ¥69.411 million in the previous fiscal year.
  7. FY2024-Q3AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative third quarter of the current consolidated fiscal year were ¥73 million.」

    Cumulative research and development expenses for the third quarter were updated to ¥73 million.
  8. FY2024-Q1AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative first quarter of the current consolidated fiscal year were ¥27 million.」

    Cumulative research and development expenses for the first quarter were updated to ¥27 million.
  9. FY2023-Q2AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative second quarter of the current consolidated fiscal year were ¥32 million.」

    Cumulative research and development expenses for the second quarter were updated to ¥32 million. There were no material changes in the status of research and development activities.
  10. FY2023-Q1AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative first quarter of the current consolidated fiscal year were ¥18 million.」

    Cumulative research and development expenses for the first quarter were updated to ¥18 million.
  11. FY2022AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥69.411 million,」

    Full-year research and development expenses were updated to ¥69.411 million, down from ¥241.227 million in the previous fiscal year.
  12. FY2022-Q2AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative second quarter of the current consolidated fiscal year were ¥34 million.」

    Cumulative research and development expenses for the second quarter were updated to ¥34 million.
  13. FY2021-Q2AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative second quarter of the current consolidated fiscal year were ¥17 million.」

    Cumulative research and development expenses for the second quarter were updated to ¥17 million.
  14. FY2021-Q1AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative first quarter of the current consolidated fiscal year were ¥15 million.」

    Cumulative research and development expenses for the first quarter were updated to ¥15 million. There were no material changes in the status of research and development activities.
  15. FY2020AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥241.227 million,」

    Full-year research and development expenses were updated to ¥241.227 million, up from ¥238.962 million in the previous fiscal year.
  16. FY2020-Q3AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative third quarter of the current consolidated fiscal year were ¥132 million.」

    Cumulative research and development expenses for the third quarter were updated to ¥132 million. There were no material changes in the status of research and development activities.
  17. FY2020-Q2AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative second quarter of the current consolidated fiscal year were ¥103 million.」

    Cumulative research and development expenses for the second quarter were updated to ¥103 million. There were no material changes in the status of research and development activities.
  18. FY2020-Q1AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative first quarter of the current consolidated fiscal year were ¥55 million.」

    The first-quarter research and development expense result was updated to ¥55 million. There were no material changes in the status of research and development activities.
  19. FY2019AdvancedAnnual report

    「Total research and development expenses for the current consolidated fiscal year were ¥238.962 million, and an overview of the activities is as follows.」

    Research and development expenses increased from ¥186.143 million in the previous fiscal year to ¥238.962 million, and the activities, including new products, fall-prevention robots and communication robots, are described in greater detail.
  20. FY2019-Q3AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative third quarter of the current consolidated fiscal year were ¥155 million.」

    Cumulative research and development expenses for the third quarter are reported at ¥155 million.
  21. FY2019-Q2AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative second quarter of the current consolidated fiscal year were ¥102 million.」

    Cumulative research and development expenses for the second quarter are reported at ¥102 million. There were no material changes in the status of research and development activities.
  22. FY2019-Q1AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative first quarter of the current consolidated fiscal year were ¥53 million.」

    Research and development expenses of ¥53 million are reported for the first quarter.
  23. FY2018AdvancedAnnual report

    「Total research and development expenses for the current consolidated fiscal year were ¥186.143 million, and an overview of the activities is as follows.」

    The research and development expense figure was updated from the cumulative quarterly amount to the full-year result of ¥186.143 million.
  24. FY2018-Q3First statedAnnual report

    「Total research and development expenses for the Group as a whole during the cumulative third quarter of the current consolidated fiscal year were ¥130 million.」

    The actual total research and development expenses for the cumulative third quarter are presented.
Moved together

"Sales growth led by walking aids, while OEM sales remained sluggish" moved the same way as this thread, in the same document, in 12 of its 24 moves.

121211101010★123456
  1. ★This thread
  2. 1Sales growth led by walking aids, while OEM sales remained sluggish12×
  3. 2Revenue and Profit Performance12×
  4. 3Increased Financing Through Long-Term Borrowings11×
  5. 4Brand Strategy and Development of a New Product Series10×
  6. 5Dividend Payments to Shareholders10×
  7. 6Strengthening the Integration of Organisational Functions and Securing and Developing Human Resources10×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Kowa yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Research and Development Expenditure | KOWA CO.,LTD. (7807) | Komori